Dr. Huimin Zhao's lab focuses on discovering new antibiotics from natural products, particularly a special group called ribosomally synthesized and post-translationally modified peptides (RiPPs). By using advanced technologies like artificial intelligence and synthetic biology, they aim to enhance the production of these promising compounds and improve the ability to predict their structures. The research ultimately seeks to address the growing problem of antibiotic resistance by developing new antibacterial agents.